Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and Drug Administration has announced that it will crack down on compounded versions of GLP-1 drugs, including the popular Hims and Hers brand.
Continue Reading this article here
